Skip to main content

Table 2 Liver function tests in patients with renal failure at start and end of intravenous voriconazole therapy

From: Accumulation of the solvent vehicle sulphobutylether beta cyclodextrin sodium in critically ill patients treated with intravenous voriconazole under renal replacement therapy

 

ASAT (IU/l)a

γ-GT (IU/l)b

Total bilirubin (mg/dl)c

 

start

end

start

end

start

end

patient no. 1

104

24

119

264

2.32

1.39

patient no. 2

100

26

93

71

0.83

0.32

patient no. 3

54

25

288

443

4.93

7.27

patient no. 4

30

22

238

216

3.29

1.34

  1. anorm < 37 IU/l, bnorm 10–66 IU/L, cnorm 0.1–1.2 mg/dl